SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): August 3, 2004
CardioTech International, Inc.
(Exact Name of Registrant as Specified in Charter)
MASSACHUSETTS |
| 000-28034 |
| 04-3186647 |
(State or other jurisdiction of incorporation) |
| (CommissionFile Number) |
| (IRS EmployerIdentification Number) |
|
|
|
|
|
229 Andover Street, Wilmington, MA 01887 | ||||
(Address of principal executive offices) (Zip Code) | ||||
|
|
|
|
|
Registrant’s telephone number, including area code (978) 657-0075 |
|
| ||
|
|
|
|
|
NOT APPLICABLE | ||||
(Former Name or Former Address, if Changed Since Last Report) |
ITEM 9. Regulation FD Disclosure.
During August, 2004, Michael Szycher, Chairman and CEO of CardioTech International, Inc. will make various presentations to select investors who either hold securities of the Company or may be interested in acquiring securities of the company. Dr. Szycher will present to the audience a presentation substantially in the form as attached hereto as Exhibit 99.1.
2
EXHIBIT INDEX
99.1 The Company’s updated presentation as part of our Investor relations activities.
3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
| CARDIOTECH INTERNATIONAL, INC. | |
|
|
| |
|
|
| |
| By: | /s/ Michael Szycher |
|
|
| Michael Szycher | |
|
| Chairman and Chief Executive Officer |
4